G&E Healthcare Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2017	FY 2016	FY 2015
Period Ending	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Operating Revenue	7,748	3,512	2,841
Other Revenue	0	-	-
Revenue	7,748	3,512	2,841
Revenue Growth (YoY)	120.61%	23.63%	-
Cost of Revenue	3,750	1,566	1,320
Gross Profit	3,998	1,946	1,521
Selling, General & Admin	1,849	1,019	948.71
Research & Development	32.97	27.5	26.19
Amortization of Goodwill & Intangibles	14.2	10.65	-
Other Operating Expenses	44.41	28.02	20.31
Operating Expenses	1,992	1,126	1,017
Operating Income	2,006	820.1	503.42
Interest Expense	-41.61	-29.7	-2.9
Interest & Investment Income	9.17	5.89	6.52
Currency Exchange Gain (Loss)	-4.12	0.48	-
Other Non Operating Income (Expenses)	-13.4	-7.3	-11.1
EBT Excluding Unusual Items	1,956	789.46	495.94
Gain (Loss) on Sale of Investments	11.63	-	-
Pretax Income	1,968	789.46	495.94
Income Tax Expense	372.54	114.25	65.24
Net Income	1,595	675.21	430.7
Net Income to Common	1,595	675.21	430.7
Net Income Growth	136.27%	56.77%	-
Shares Outstanding (Basic)	9	0	0
Shares Outstanding (Diluted)	9	0	0
Shares Change (YoY)	199892.84%	118.06%	-
EPS (Basic)	183.00	154899.29	215457.23
EPS (Diluted)	183.00	154899.29	215457.23
EPS Growth	-99.88%	-28.11%	-
Free Cash Flow	2,989	-80.34	196.47
Free Cash Flow Per Share	342.90	-18429.69	98284.64
Gross Margin	51.60%	55.41%	53.53%
Operating Margin	25.89%	23.35%	17.72%
Profit Margin	20.59%	19.22%	15.16%
Free Cash Flow Margin	38.58%	-2.29%	6.92%
EBITDA	2,133	883.82	547.58
EBITDA Margin	27.53%	25.16%	19.27%
D&A For EBITDA	126.61	63.73	44.17
EBIT	2,006	820.1	503.42
EBIT Margin	25.89%	23.35%	17.72%
Effective Tax Rate	18.93%	14.47%	13.15%
Advertising Expenses	607.5	411.92	437.95

Source: S&P Global Market Intelligence. Standard template. Financial Sources.